Ray Therapeutics, Inc.

Developing novel optogenetics gene therapies for patients with blinding diseases

[California Institute for Regenerative Medicine @CIRMnews]

CIRM has awarded nearly $8 million to @RayTherapeutics to support a Phase 1 clinical trial for retinitis pigmentosa (RP), a rare, degenerative eye disease with no cure. This marks the 116th CIRM-funded clinical trial.

https://t.co/4kJzCJh0g2

[Ray Therapeutics, Inc. @RayTherapeutics]

We’re thrilled to welcome Christopher Whitmore as CFO.

Mr. Whitmore is a highly accomplished executive who brings over 20 years of strategic finance, accounting, and operational expertise to our team.

Read the release:

https://t.co/6u3ZLm4gqE

[Ray Therapeutics, Inc. @RayTherapeutics]

Our CEO Jenny Holt moderated a great session today at @LSXLeaders in Boston. Thanks to all the panelists and everyone who attended the session!

[Ray Therapeutics, Inc. @RayTherapeutics]

Our Chief Development Officer Jenny Holt is speaking at @LSXLeaders #LSXCongress in Boston today at 11 am ET.

Check out the agenda:

https://t.co/54kOCZBPjP

[Ray Therapeutics, Inc. @RayTherapeutics]

.@surfernan speaks with our CEO Paul Bresge for Raising Biotech podcast.
Listen here: #optogenetics

https://t.co/Tv0zxL3yO6

[Bakar Labs @bakarlabs_uc]

"You're going blind, there's nothing that can be done." Motivation for Paul Bresge to launch jCyte & @RayTherapeutics to find cure for #retinitispigmentosa, the blinding disease his daughter Tamar was diagnosed with. Story by @holyguacamollie in @biospace https://t.co/tEXnnUGZuP

[Ophthalmology Innovation Source @OISTWEETS]

This week's podcast features industry leaders sharing valuable insights on early commercial strategy and navigating the journey from regulatory approval to commercialization. This #OISXIII panel is a must-listen for anyone in the industry!

Listen Now: https://t.co/ENrQcfunqH

[Fierce Life Sciences Events @LifeSciEvents]

💡JPM 2024 Featured Session with Jenny Holt (@RayTherapeutics), Chris McDonald (@KitePharma), A Gilead Company, Morten Sogaard (@AstellasGeneTx), and Brian Riley (@BeamTx)
Register Here: https://t.co/UtODpkkhRg
#FierceJPMWeek #JPMWeek

[Ray Therapeutics, Inc. @RayTherapeutics]

.@RegMedNet covers our funding news from @CIRMnews:

https://t.co/O4iuvx8QrV

[Ray Therapeutics, Inc. @RayTherapeutics]

.@BioWorld covers our recent funding from @CIRMnews:

https://t.co/IISub1jicJ

[Vision Monday @VisionMonday]

Ray Therapeutics Receives $4 Million in Funding from the California Institute for Regenerative Medicine to Advance Optogenetic Therapy https://t.co/QVOQmdyxkJ

[RegMedNet @RegMedNet]

🟢Cell therapy weekly:

@RayTherapeutics has been awarded US$4 million grant to advance optogenetic therapy

@LegendBiotech and @Novartis form partnership a strategic partnership

@InGeneronInc reports positive data for rotator cuff tear cell therapy!

[Bakar Labs @bakarlabs_uc]

Congratulations Paul Bresge & team! "The treatment delivers light sensing channel rhodopsin to retinal cells, to potentially restore vision using the power of #optogenetics"

[Tech Startups @thetechstartups]

Ray Therapeutics secures $4M from CIRM to develop optogenetic therapy treatment for geographic atrophy @RayTherapeutics #Funding #BioTech #Startups #optogenetics #CIRM #optogenetic #therapy #BreakingNews #Breaking https://t.co/ggclaQmp9g

[Ray Therapeutics, Inc. @RayTherapeutics]

Excited to announce we’ve been awarded $4M by @CIRMnews to develop RTx-021 for the treatment of geographic atrophy age-related macular degeneration.

Read the full release:

https://t.co/X7Xt6iMGmJ

[Ray Therapeutics, Inc. @RayTherapeutics]

Our Chief Development Officer @holthut3 speaks with @BioProcessOL and @ForgeBio about #CDMOs and what’s constitutes a good partnership.

Listen here:
👇👇👇

https://t.co/8yT0H4tNBF

[Biocom @Biocom]

Happy #NewMemberMonday!
🥼@ExpericServices is a CDMO focused on the needs of small, midsize & specialty pharmas
🏢@KSProp removes real estate obstacles for science companies
👁️@RayTherapeutics is on a mission to restore vision with the power of optogenetics

[Ray Therapeutics, Inc. @RayTherapeutics]

Our CEO Paul Bresge will be speaking on Oct 5 at @lottenypalace in NYC at
 3 pm - Rewriting the Code: Navigating the Frontier of Gene & Cell Therapy

@leilei_wuu @endpts will be moderating the panel. Other panelists include @jura_bio @AurionBiotech @immusoft @ExcisionBio